Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma
The primary objective of this study is to assess the safety and effectiveness of ABT-510 in subjects with locally advanced or metastatic soft tissue sarcoma.
Sarcoma, Soft Tissue
DRUG: ABT-510 - Thrombospondin-1 mimetic
Progression free survival, One year
Response rate, One year|Overall survival, One year|Performance status, One year
The primary objective of this study is to assess the safety and effectiveness of ABT-510 in subjects with locally advanced or metastatic soft tissue sarcoma.